LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer

This study is currently recruiting participants.

Study NCT00805194 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: December 8, 2008 Last Updated: October 12, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	August 2012 (Final data collection date for primary outcome measure)